EQ: Equillium, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 16.83
Enterprise Value ($M) -1.26
Book Value ($M) 19.06
Book Value / Share 0.54
Price / Book 0.88
NCAV ($M) 18.43
NCAV / Share 0.52
Price / NCAV 0.91

Profitability (mra)
Return on Invested Capital (ROIC) -0.41
Return on Assets (ROA) -0.19
Return on Equity (ROE) -0.38

Liquidity (mrq)
Quick Ratio 3.93
Current Ratio 3.93

Balance Sheet (mrq) ($M)
Current Assets 24.98
Assets 25.60
Liabilities 6.54
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 41.09
Operating Income -8.27
Net Income -8.07
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -19.03
Cash from Investing 13.81
Cash from Financing 0.16

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-14 13G/A Decheng Capital Management IV (Cayman), LLC 15.60

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-21 33,960 44,451 76.40
2025-04-17 20,098 71,793 27.99
2025-04-16 22,978 71,476 32.15

(click for more detail)

Similar Companies
ENTX – Entera Bio Ltd. ENVB – Enveric Biosciences, Inc.
EPIX – ESSA Pharma Inc. ERNA – Ernexa Therapeutics Inc.
ESLA – Estrella Immunopharma, Inc.


Financial data and stock pages provided by
Fintel.io